PAX4 has the potential to function as a tumor suppressor in human melanoma

  • Authors:
    • Shinya Hata
    • Jun-Ichi Hamada
    • Kazuhiko Maeda
    • Taichi Murai
    • Mitsuhiro Tada
    • Hiroshi Furukawa
    • Arata Tsutsumida
    • Akira Saito
    • Yuhei Yamamoto
    • Tetsuya Moriuchi
  • View Affiliations

  • Published online on: November 1, 2008     https://doi.org/10.3892/ijo_00000095
  • Pages: 1065-1071
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We hypothesize that dysregulated expression levels of the developmental regulatory genes in the adult body result in tumor development and malignant progression. PAX genes discovered as human orthologous genes of Drosophila ‘paired’ encode transcription factors, which control the expression of target genes to go on along the program of development. In this study, we first quantified expression of 9 PAX genes in human nevus pigmentosus tissues, melanoma tissues and melanoma cell lines by the real-time reverse transcription-PCR method. As a result, we found that the expression levels of PAX4 and PAX9 were extremely low in melanoma tissues and cell lines compared to nevus pigmentosus tissues. We then established melanoma cells overexpressing PAX4 and examined roles of PAX4 in cell growth. PAX4-overexpression reduced in vitro cell growth of human melanoma C8161 and MeWo cells. BrdU-uptake assay and cell cycle analysis by flow cytometry indicated that the retardation of cell proliferation by PAX4-overexpression was due to decreased DNA synthesis and cell cycle arrest at the G0/G1 phase. Furthermore, treatment of C8161 and MeWo cells with 5-azacytidine, a DNA demethylating agent, induced the expression of PAX4, suggesting that DNA methylation repressed the PAX4 gene expression in human melanoma. These results suggest that PAX4 functions as a potent tumor suppressor.

Related Articles

Journal Cover

November 2008
Volume 33 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hata S, Hamada J, Maeda K, Murai T, Tada M, Furukawa H, Tsutsumida A, Saito A, Yamamoto Y, Moriuchi T, Moriuchi T, et al: PAX4 has the potential to function as a tumor suppressor in human melanoma. Int J Oncol 33: 1065-1071, 2008.
APA
Hata, S., Hamada, J., Maeda, K., Murai, T., Tada, M., Furukawa, H. ... Moriuchi, T. (2008). PAX4 has the potential to function as a tumor suppressor in human melanoma. International Journal of Oncology, 33, 1065-1071. https://doi.org/10.3892/ijo_00000095
MLA
Hata, S., Hamada, J., Maeda, K., Murai, T., Tada, M., Furukawa, H., Tsutsumida, A., Saito, A., Yamamoto, Y., Moriuchi, T."PAX4 has the potential to function as a tumor suppressor in human melanoma". International Journal of Oncology 33.5 (2008): 1065-1071.
Chicago
Hata, S., Hamada, J., Maeda, K., Murai, T., Tada, M., Furukawa, H., Tsutsumida, A., Saito, A., Yamamoto, Y., Moriuchi, T."PAX4 has the potential to function as a tumor suppressor in human melanoma". International Journal of Oncology 33, no. 5 (2008): 1065-1071. https://doi.org/10.3892/ijo_00000095